Answers are grounded in this paper and cite their sources.
Antimicrobial resistance represents a growing global health crisis, leading to increased morbidity, mortality, and economic burdens on healthcare systems. The urgent need for novel therapeutic strategies against resistant bacterial strains has driven extensive research into alternative bioactive compounds. This systematic review evaluates the antimicrobial potential of 30 aminonitrile derivatives, analyzing their structure-activity relationships and pharmacological properties. Among these, 11 compounds exhibited potent antibacterial activity, particularly against Staphylococcus aureus and Escherichia coli. Structural analysis revealed that halogenated substituents, especially chlorine and fluorine, play a critical role in enhancing antibacterial efficacy. Furthermore, aminonitriles demonstrated promising anticancer properties and antifungal activity against Candida albicans, expanding their therapeutic potential beyond bacterial infections. Despite the limited number of studies, the available evidence strongly supports further exploration of aminonitriles as promising scaffolds for next-generation antimicrobial agents. Future investigations should focus on comprehensive preclinical studies, including mechanistic insights, toxicity profiling, and optimization of molecular modifications to maximize their clinical applicability.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: